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Abstract: Because the effects of age, menopausal status, weight and body mass index (BMI) on
ovarian detectability by transvaginal ultrasound (TVS) have not been established, we determined
their contributions to TVS visualization of the ovaries. A total of 29,877 women that had both
ovaries visualized on their first exam were followed over 202,639 prospective TVS exams. All images
were reviewed by a physician. While visualization of both ovaries decreased with age, one or both
ovaries could be visualized in two of every three women over 80 years of age. Around 93% of
pre-menopausal women and ~69% of post-menopausal women had both ovaries visualized. Both
ovaries were visualized in ~72% of women weighing over 300 lbs. and in ~70% of women with a
BMI over 40. Conclusions: Age had the greatest influence on the visualization of the ovaries. The
ovaries can be visualized well past the menopause. Body habitus was not limiting to TVS ovarian
imaging, and TVS should be considered capable of imaging one or both ovaries in two of every three
women over 80 years of age. Thus, older and obese patients remain good candidates for TVS exams.

Menopausal Status and Body Type.
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1. Introduction
Transvaginal ultrasonography (TVS) is used as the first-line imaging approach by radiologists, gynecologists and gynecologic oncologists for the evaluation of women suspected
to have an adnexal mass that could be a malignant ovarian cancer [1]. TVS requires no
preparation, is well-tolerated, is free of radiation, can be completed quickly and yields high
quality detailed images of the pelvis [2], including early and late-stage malignancies of the
uterus [3] and ovary [4–7]. TVS has been reported to be significantly more accurate than bimanual clinical examination in detecting the ovaries especially since ovaries frequently are
not palpable in women over 55 years of age, or in women weighing more than 200 lbs. [8,9].
Although useful, safe and in wide clinical application, the ultimate limits of modern ultrasonographic instrumentation to detect human ovaries have not been fully characterized. We
have reported on ovarian size determined by TVS in a large screening population [10,11],
but little is known about how the detectability of the ovaries is influenced by age, body
habitus and menopausal status. Importantly, the expectation that ovarian structure may
or may not be viewable by TVS can directly impact patient care, especially if imaging is
not performed in circumstances when visualization is possible. For example, if a patient is
perceived as too old for the ovaries to be visible by TVS, she may only receive a bimanual
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exam. Consequently, the detection of adnexal pathology may be missed by the physical
exam and treatment delayed. However, with an accurate evidence-based perception of the
likelihood of ultrasound being able to visualize the ovaries, the opportunity to receive a
timely and safe TVS exam will increase the prospects for a clinical intervention if needed.
The objective of this study was to understand how age, menopausal status, weight and
BMI influence TVS visualization of the ovaries in order to provide accurate expectations
for the likelihood of TVS to successfully visualize these structures.
2. Materials and Methods
A total of 46,814 women who enrolled in the University of Kentucky Ovarian Cancer
Screening Trial (UKOCST) from January 1987 to June 2018 were evaluated. This prospective
cohort trial was approved by the University of Kentucky Institutional Review Board for
Human Studies (IRB# 45030) and is registered at ClinicalTrials.gov: NCT04473833. The informed consent was approved institutionally and administered by the study sonographers
who were also able to answer questions from participants. Eligibility criteria included
(1) all asymptomatic women aged ≥50 years, and (2) asymptomatic women aged ≥25 years
with a documented family history of ovarian cancer in at least one primary or secondary
relative. All study participants completed a questionnaire that included medical history,
surgical history, menopausal status, hormonal use and family history of cancer, as previously published [3]. Menopause was defined when women self-reported that they had
not experienced menses for 12 consecutive months. This definition of menopause is not as
comprehensive as the World Health Organization definition [12], which includes demonstrated loss of ovarian follicular activity or follicle depletion. The definition used here is as
described by the National Institute of Aging [13] and is well-suited for self-reporting. In
the self-reporting context, perimenopause was defined as ovulation that is unpredictable
with the length of time between periods becoming longer or shorter, or the skipping of
some periods or a persistent change of seven days or more in the length of the menstrual
cycle [14]. Women with a known ovarian tumor or a personal history of ovarian cancer
were excluded from the present investigation.
Transvaginal ultrasonography and color Doppler were performed using General
Electric Voluson P5, P8 and P10 units with a 4 to 11 mHz vaginal probe on women with
an empty bladder. In performing the TVS exam, the transducer was gradually inserted
while observing the ultrasound image on a monitor. The urinary bladder was used as a
consistent landmark in the pelvis relative to much more variable positions of the uterus
and the ovaries for assessing the orientation of the transducer. Three scanning approaches
were used to comprehensively assess the pelvis:
(a)
(b)
(c)

Aide-to-side movements to achieve sagittal imaging,
90◦ rotation to obtain semi-coronal images and angulation of the probe vertically,
Varying the depth of probe insertion to expose different pelvic structures within the
field of view.

The pelvis was surveyed by slowly sweeping the beam in a sagittal plane from the
midline to the lateral pelvic side walls followed by turning the probe 90 degrees into the
coronal plane and sweeping the beam from cervix to the fundus. Landmarks for proving
structure consisted of identifying the iliac vessels in the pelvic sidewall and the tubal
vessels located posterior and parallel to the fallopian tubes. Pressure was applied to at least
three regions of the abdominal surface to achieve bowel repositioning in order to assist
visualizations. All images were reviewed by a physician and by at least one of the authors.
The study protocol specified that ovaries be measured in three dimensions. Ovarian volume
was calculated using the prolate ellipsoid formula (length × width × height × 0.523) [15,16].
Thus, a visualization event was validated by findings that obtained all three measurements.
All screening information was entered into a database (MEDLOG Systems, Crystal Bay,
NV, USA) on a local network. Women who had a normal screen were scheduled to
return in 12 months for a repeat screen. Only women with two visible ovaries on their
first TVS encounter were utilized in this study and then followed over the course of
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annual examinations by TVS. Women who underwent abdominal surgery were censored
from the present analysis so that surgical interventions did not influence visualization
outcomes. Because women with a single visualized ovary are already in a transition to nonvisualization, we made the assumption that the transition to the loss of ultrasonographic
ovarian visualization should begin when both ovaries were present initially so that the
incidence of complete non-visualization could be accurately estimated.
Statistical Analyses
For all analyses, a two-sided significance level of p < 0.05 was considered statistically
significant. The rate of an event (r) was determined as the proportion in a group with both
ovaries visualized (r = [Nvisualized /[Nnonvisualized + Nvisualized ]]). The probability ratio (PR)
for each group was determined as the rate of visualizing both ovaries in each age group
(RG ) relative to the rate of visualizing both ovaries in the comparison age group (Rcomparison )
where 20–30-year-old women comprised the comparison group (PR = RG /Rcomparison ). The
odds of an event (O) were determined as those in a group with both ovaries visualized
relative to those where both ovaries were not visualized (O = [Nvisualized /[Nnonvisualized ]]).
The odds ratio (OR) for each group was determined as the odds of visualizing both ovaries
in an age group (OG ) relative to the odds of visualizing both ovaries in the comparison group (Ocomparison ) where 20–30-year-old women comprised the comparison group
(OR = OG /Ocomparison ). Rates, probability ratio, odds, odds ratio, log odds, Phi coefficient
of association, Chi-square test of association with Yates and Pearson p-values, Fisher exact
probability test, multiple regression analysis and confidence intervals were obtained using
VassarStats based on logistic regression [17].
3. Results
In total, 29,877 women were identified that had both ovaries visualized on their first
TVS exam and were subsequently followed over a course of 202,639 prospective TVS exams.
Their demographic characteristics are presented in Table 1.
Table 1. Demographic characteristics of women undergoing TVS. Data represented as mean, median, range in parentheses. Subject data are for first encounter, while encounter data are across
all encounters.

Age (y)
Weight (kg)
Height (cm)
BMI
Pre-menopausal
Peri-menopausal
Post-menopausal

All Subjects
(n = 29,877)

All Encounters
(n = 202,639)

55.0, 55
(20–91)
73, 70.3
(38–204)
163.5, 162.6
(119–198)
27.3, 26
(13–80)
5966 (20.9%)
1262 (4.4%)
21,251 (74.6%)

60.1, 60
(20–95)
72.3, 69.4
(36–205)
163.6, 162.6
(119–198)
27, 26
(13–80)
28,618 (14.3%)
5820 (2.9%)
165,390 (82.8%)

Age—Visualization of both ovaries decreased with age, but one or both ovaries could
be visualized in two of every three women over 80 years of age, while 50% of patients aged
77–78 had both ovaries identified (Figure 1 dashed line). The line of best fit for visualization
of both ovaries is shown in green (5th degree polynomial, (r = 0.9992), y = 102.097937
− 5.571464X + 2.739043X2 − 0.626314X3 + 0.048908X4 − 0.001299X5 ). The 5th degree
polynomial line of best fit for visualization of neither ovary (red line) was y = −0.065979 +
0.719492X − 0.485964X2 + 0.113695X3 − 0.005843X4 + 0.000076X5 (r = 0.9996). A crossover
point was noted for women in their mid-80s, where non-visualization of both ovaries
was greater than visualization. The profile for visualization of neither ovary increased
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after age 50 (Figure 1, red line) to a maximum after age 85 of 35%. After age 40, both the
probability ratio of visualizing both ovaries and the odds ratio were significantly different
(p < 0.001), Table 2.

Figure 1. Ovarian visualization relative to age. Sonographic findings visualizing both ovaries (black
line), one ovary (blue line) or neither ovary (red line). Age was self-reported and associated with
202,639 TVS encounters. Percentages were determined within each age group. The profile for the
visualization of both ovaries was very well fitted by a 5th degree polynomial (Figure 1, green line,
r = 0.9992) for the probability of visualization over the range 25–90 years of age. n = number of
TVS observations.

Body Habitus—Neither weight (Figure 2A, p > 0.2) nor BMI (Figure 2B, p > 0.12) was
independently associated with ovarian visualization since visualization of both ovaries
was ~70% across all weights and BMIs. Adjustable probe frequency allowed both ovaries
to be visualized in ~72% of women that weighed over 300 lbs. (Figure 2A) and in ~70%
of women with a BMI over 40. No more than a 4% difference occurred over the range of
100–300+ lbs. (50–130 kg) or BMIs of 16–40+ (Figure 2B).
Menopausal Status—Menopausal status was self-reported. Both ovaries were visualized in ~93% of pre-menopausal women and ~69% of post-menopausal women (Figure 2C,
p < 0.001).
Multiple regression analysis by the direct method did not support a model where all
variables (R2 = 0.09347) significantly contributed to predicting visualization of both ovaries.
In this model, each unit change in age was the most significant predictor (p < 0.0001), while
change in BMI was 8% of age, menopausal status was 5% of age and weight was 4% of age,
supporting the data shown in Figures 1 and 2.
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Table 2. Probability and odds ratios of ovarian visualization by age. The 95% confidence interval is
in parentheses.
Age (yrs)

Total n

Both Ovaries
Visualized

PR [95% CI]

OR [95% CI]

20–30

1182

1170

1

1

31–35

2439

2366

0.98
(0.9712–0.9889)

0.3324
(0.1798–0.6146)

36–40

5103

4943

0.9786
(0.9712–0.9860)

0.3169
(0.1756–0.5717)

41–45

8483

8019

0.955
(0.9477–0.9624)

0.1773
(0.0996–0.3154)

46–50

13,096

12,056

0.93
(0.9229–0.9372)

0.1189
(0.0671–0.2107)

51–55

33,202

28,463

0.8661
(0.8598–0.8724)

0.0616
(0.0349–0.1089]

56–60

39,278

30,132

0.775
(0.7689–0.7812)

0.0338
(0.0191–0.0597)

61–65

38,077

26,396

0.7003
(0.6942–0.7065)

0.0232
(0.0131–0.0409)

66–70

30,164

18,522

0.6203
(0.6138–0.6270)

0.0163
(0.0092–0.0288)

71–75

18,823

10,210

0.548
(0.5402–0.5559)

0.0122
(0.0069–0.0215)

76–80

9077

4221

0.4698
(0.4592–0.4806)

0.0089
(0.0050–0.0158)

81–85

3009

1092

0.3666
(0.3496–0.3845)

0.0058
(0.0033–0.0104)

>85

706

224

0.3205
(0.2876–0.3572)

0.0048
(0.0026–0.0086)

Figure 2. Cont.
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Figure 2. Ovarian visualization relative to weight, BMI and menopausal status. Panel (A): Weight was
reported in 207,371 TVS encounters. Panel (B): Weight and height were reported for the calculation
of BMI in 213,793 TVS encounters. Panel (C): Menopausal status was self-reported at the time of
the TVS exam in 199,828 TVS encounters. Sonographic findings visualizing both ovaries (black bar),
one ovary (blue bar) or neither ovary (red bar). Differences in the number of TVS exams reflect
unreported events (missing data) resulting in exclusion from analysis. Percentages were determined
for each grouping.

4. Discussion
TVS should be considered capable of imaging one or both ovaries in two of every
three women over 80 years of age. Weight and BMI had little effect on ovarian visualization. Likewise, body habitus was not an independent factor limiting ovarian imaging.
Menopause should not be interpreted as an absolute indicator that limits sonographic
ovarian visualization, although it is related to age. The importance of the present report
is that neither body habitus nor menopausal status was found to significantly impair the
ability of TVS to visualize the ovaries.
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4.1. Clinical Implications
Age-related estimates of ovarian visualization described here indicate that the application of TVS imaging should be considered viable for elderly women so that age should not
be used to deny access to TVS. With modern ultrasonographic instrumentation, age should
not deter a physician’s decision for sonographic exploration of the ovaries. Importantly, the
opportunity to visualize the ovaries is also viable across the full range of weights and BMIs.
Obesity and extreme obesity have become more prevalent in American women, increasing
from 10% in 1979–1980 to 40+% in 2013–2014 [18]. This increase has been suggested to
present a mounting challenge to obtaining high quality TVS images of the abdomen [19].
Abdominal ultrasound is widely considered the radiologic approach most affected by obesity because the depth of insonation needed in very large women attenuates the ultrasound
beam. However, TVS reduces the distance between the vaginal transducer and pelvic
structures allowing detailed visualization of the ovaries. TVS lacks ionizing radiation and
is not subject to absolute weight/girth restrictions as are CTs or MRIs. TVS provides an
opportunity to bypass the abdominal apron of excessive skin and fat that characterizes
obesity. Glanc et al. have reported that there is a paucity of evidence-based literature on the
implications of obesity on TVS [15]. Here we report that modern TVS instrumentation is
capable of achieving equivalent ovarian visualization in both obese and non-obese women.
Because of the substantial number of ultrasound cases in the current study, the findings
reported here can be confidently relied upon in the clinical setting.
4.2. Research Implications
The results reported here are prospective findings gleaned from long-term data collection in a large ovarian screening study. While it could be possible that newer instrumentation employed over the 30-year course of data collection might influence visualization;
however, there was only a 2.6% increase in the visualization of both ovaries in the most
recent 15 years of TVS over the first 15 years. This estimate relies on having sufficient
numbers in the groups used to compare effects due to advances in ultrasound technology.
Indeed, in the first five years of the screening program, visualizations of both ovaries
were 30.2% (n = 2068) less than the most recent 15 year experience (n = 24,808), while
this difference decreased to 0–6% with each 10 year increment, indicating that the earliest
ultrasound instruments in this study performed less well. However, the bias represented
by these early screens is limited because they account for only 4.4% of the total first screen
observations (2068/46,814). Although admission to the study was weighted so that the
number of women at least 50 years of age (85%) was greater than women younger than
50 years of age (15%), a substantial number of measurements (n = 30,303) were collected
for the younger age group. Future investigations should focus on identifying factors correlated with aging that contribute to failures to visualize the ovaries, including bladder and
bowel dysfunction.
4.3. Strengths and Limitations
The strengths of this paper arise from the large group size of this prospectively studied
cohort of asymptomatic women and from criteria for reporting ovarian visualization
involving measurement in three planes. By concentrating on women that had both ovaries
visualized on their first encounter, this study avoids any timing bias originating in ovarian
events occurring prior to entry into the study. The primary timing bias is minimized
by examining the transition to complete non-visualization from when both ovaries are
visualized. It is possible that the group studied varies from the symptomatic population
seen in the clinic, which may affect generalizability; however, women with abnormal TVS
findings are included in this study as they constitute a visualization event. Women whose
ovaries were removed were excluded; yet, any bias presented by those that were excluded
is small, representing ~2.5% of the women with both ovaries visualized on the initial
TVS exam.
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5. Conclusions
Age had the greatest influence on the visualization of the ovaries. Although menopause
is often perceived as associated with aging, both ovaries could be visualized well past
the onset of menopause. In the majority of women, the ovaries could be visualized for
20–25 years beyond menopause which occurs on average at age 50 [20–22]. The present
paper provides evidence that the evaluation of ovarian structure using TVS is possible at
almost any age and weight. Thus, older and obese patients remain good candidates for TVS
exams, providing solution to the limitations that occur with physical examination [8,9].
Author Contributions: E.J.P. had complete access to all of the data in this study and accepts responsibility for the integrity of the data and the accuracy and interpretation of the data analysis. Concept,
design and approaches, E.J.P.; acquisition, analysis and interpretations of data, E.J.P. and E.B.; drafting
of the manuscript, E.J.P.; critical revision of the manuscript for important intellectual content, E.J.P.,
J.G., L.B.-B., R.M., C.P.D., C.S.D., H.S.G., F.R.U., J.R.v.N.J.; statistical analysis, E.J.P.; funding, E.J.P.
and J.R.v.N.J.; administrative, technical or material support, E.B.; supervision, E.J.P. All authors have
read and agreed to the published version of the manuscript.
Funding: This research was funded by the Kentucky Department of Health and Human Services
grant number 202007161438 and the Telford Foundation.
Institutional Review Board Statement: The study was conducted according to the guidelines of
the Declaration of Helsinki and approved by the Institutional Review Board of the University of
Kentucky (protocol code 45030 and recent date of approval: 31 January 2022). CLINICAL TRIAL
REGISTRATION: OnCore Clinical Trials Management System, NCI-2013-01954, ClinicalTrials.gov:
NCT04473833 (https://clinicaltrials.gov/ct2/show/NCT04473833?term=NCT04473833&draw=2&
rank=1 (accessed on 5 January 2021)).
Informed Consent Statement: Informed consent was obtained from all subjects involved in the study.
Data Availability Statement: De-identified data sharing is available after institutional approval by
the University of Kentucky and the requestor’s institution/employer through Institutional Review
Board approved protocols at each.
Acknowledgments: We acknowledge the participation of women in the Kentucky Extension Homemakers Association and their financial support.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or
in the decision to publish the results.

References
1.

2.
3.

4.

5.
6.
7.
8.
9.

Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer. NCCN Clinical Practice Guidelines in Oncology.
Version 3. 9 September 2021. Available online: https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf (accessed
on 27 December 2020).
Moorthy, R.S. Transvaginal Sonography. Med. J. Armed Forces India 2000, 56, 181–183. [CrossRef]
Jacobs, I.; Gentry-Maharaj, A.; Burnell, M.; Manchanda, R.; Singh, N.; Sharma, A.; Ryan, A.; Seif, M.W.; Amso, N.N.; Turner, G.;
et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: A case-control study
within the UKCTOCS cohort. Lancet Oncol. 2011, 12, 38–48. [CrossRef]
Van Nagell, J.; Burgess, B.; Miller, R.; Baldwin, L.; DeSimone, C.; Ueland, F.; Huang, B.; Chen, Q.; Kryscio, R.; Pavlik, E. Survival
of Women with Type I and II Epithelial Ovarian Cancer Detected by Ultrasound Screening. Obstet. Gynecol. 2018, 132, 1091–1100.
[CrossRef] [PubMed]
Suh-Burgmann, E.; Brasic, N.; Jha, P.; Hung, Y.Y.; Goldstein, R.B. Ultrasound characteristics of early-stage high-grade serous
ovarian cancer. Am. J. Obstet. Gynecol. 2021, 225, 409.e1–409.e8. [CrossRef] [PubMed]
Cohen Ben-Meir, L.; Mashiach, R.; Eisenberg, V.H. External Validation of the IOTA Classification in Women with Ovarian Masses
Suspected to Be Endometrioma. J. Clin. Med. 2021, 10, 2971. [CrossRef] [PubMed]
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